Transcript IVI - UN in Korea

IVI Overview
December 10, 2014
VISION
Developing countries
free of suffering
from infectious disease
MISSION
Discover, develop, and deliver
safe, effective, and affordable vaccines
for the world’s developing nations
2
Background
• International Organization
– UNDP initiative
– First International Organization in Korea
– 35 countries and WHO as state parties
• Global Vaccine Research Institute
– Lab facilities in Seoul
– Field programs in >20 countries: Asia,
Africa, Latin America
3
IVI Organization
4
Global Footprint
5
Signatories to IVI’s Establishment Agreement
Bangladesh
Bhutan
Brazil
China
Ecuador
Egypt
India
Indonesia
Israel
Jamaica
Kazakhstan
Korea
Kyrgyzstan
Lebanon
Liberia
Malta
Mongolia
Myanmar
Nepal
Netherlands
Oman
Pakistan
Panama
PNG
Peru
Philippines
Romania
Senegal
Sri Lanka
Sweden
Tajikistan
Thailand
Turkey
Uzbekistan
Vietnam
WHO
*States approved by the IVI BOT for accession; Instrument of Accession to be deposited
with the UN Secretary General
Cote D’Ivoire
Kuwait
Slovakia
Spain
Sudan
UAE
6
Funding
• Major donors:
• As host country, Korea contributes to annual
operating budget and provided IVI’s
headquarters building
7
Major Achievements
WHO prequalification of oral cholera
vaccine (Shanchol™) in September 2011
Technology transfer driver in Asia – tech
transferred new and improved vaccines
against cholera and typhoid
Leader in generating evidence for
vaccine introduction in developing
countries
8
“Bench to Patient” Approach
Discovery
Development
Introduction
• Genotyping of
pathogens
• Novel antigens,
adjuvants
• New delivery
mechanisms, routes of
administration
• Process development
• Assay development
• Technology transfer
• Clinical trials
• Licensure, WHO PQ
• Demonstration campaigns
• Epidemiologic studies
• Policy & economic
research
• Advocacy
• Training
SUSTAINABLE VACCINE INTRODUCTION
9
Vaccine Portfolio and Pipeline
Discovery
Development
Delivery
Cholera
Typhoid
Bivalent typhoid/
paratyphoid
Shigella
Norovirus
Pneumococcal
conjugate (Vi-PspA)
Inactivated polio
Pediatric
multivalent
10
Vaccine Programs
• Accelerate the development and delivery of
safe, effective and affordable vaccines:
– Cholera: acute watery diarrhea; can be fatal if
untreated
– Typhoid: enteric fever; can be fatal if untreated
– Dengue: “breakbone” fever; mosquito-borne
11
Capacity-building
• Vaccinology Course
• Symposia, workshops
• North Korea Program
• Technology transfer
• Korean graduate /
post doc training
12
IVI and MOFA
• MOFA: IVI stakeholder and partner
– Representative on IVI Board of Trustees
– Support with signatory engagement
• KOICA
– Meningitis in Niger Project
– Technical advice and assistance
13
Thank You!